Euphrates Vascular raised $5,984,167 in early June of this year, according to CrunchBase.
The small St. Louis startup was founded in 2009, develops medical devices to treat vascular occlusions (blockages in a blood vessel). Note: CrunchBase says the company was founded in 2018, but the site Mergr.com, in a post from 2014 about a Lewis & Clark Capital investment into Euphrates Vascular, says it was 2009. The particulars of that investment were not disclosed, but the investment itself doesn’t show up at all on CrunchBase.
In January of 2019 the company acquired another St. Louis startup called Pulse Therapeutics for an undisclosed sum, then quickly merged with ICHOR Vascular of Florida – both startups with treatments for arterial problems.
Euphrates Vascular CEO Sean Morris was contacted by phone and LinkedIn for comment on this story, but declined to do so.
Links:
